ACADIA Pharmaceuticals Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for ACADIA Pharmaceuticals Inc. (ACAD) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents0.320.190.110.150.330.700.47
Short-Term Investments0.440.250.300.370.310.000.00
Cash & Short-Term Investments0.760.440.420.520.630.700.47
Accounts Receivable0.100.100.060.060.050.040.03
Inventory0.020.040.010.010.010.010.00
Other Current Assets0.060.040.020.010.030.010.00
Total Current Assets0.940.620.510.620.720.760.53
Non-Current Assets
Property, Plant & Equipment (Net)0.050.060.060.070.060.010.00
Long-Term Investments0.000.000.000.000.000.000.00
Intangible Assets0.120.070.000.000.000.000.00
Other Non-Current Assets0.080.010.020.020.010.010.01
Total Non-Current Assets0.250.130.070.080.070.020.01
Total Assets1.190.750.590.700.780.780.54
Current Liabilities
Accounts Payable0.020.020.010.010.010.070.04
Short-Term Debt0.010.000.000.000.000.000.00
Accrued Liabilities0.320.180.100.050.090.000.00
Other Current Liabilities0.100.030.030.030.030.020.00
Total Current Liabilities0.390.250.130.100.110.070.06
Non-Current Liabilities
Long-Term Debt0.040.050.050.060.040.010.00
Other Non-Current Liabilities0.020.020.010.010.010.000.00
Total Non-Current Liabilities0.060.060.060.060.050.010.00
Total Liabilities0.450.320.190.160.160.080.06
Stockholders' Equity
Common Stock0.000.000.000.000.000.000.00
Retained Earnings-2.20-2.43-2.37-2.15-1.99-1.70-1.47
Accumulated Other Comprehensive Income0.000.000.000.000.000.000.00
Additional Paid-in Capital2.942.862.772.692.612.401.95
Shares Outstanding0.170.160.160.160.000.000.00
Total Stockholders' Equity0.730.430.400.540.630.700.48
Total Liabilities & Equity1.190.750.590.700.780.780.54